E-LIB Suche - Ergebnisse für: Angelova, Assia L. - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Virotherapy in Germany : recent activities in virus enginee..:

Nettelbeck, Dirk M ; Leber, Mathias F ; Altomonte, Jennifer...
http://dx.doi.org/10.18725/OPARU-47550. , 2023

Link: https://doi.org/10.18725..

2

Virotherapy in Germany—Recent Activities in Virus Engineeri..:

Nettelbeck, Dirk M ; Leber, Mathias F ; Altomonte, Jennifer...
1999-4915. , 2021

Link: https://depositonce.tu-b..

3

Virotherapy in Germany—Recent Activities in Virus Engineeri..:

Nettelbeck, Dirk M ; Leber, Mathias Felix ; Altomonte, Jennifer...
https://repository.publisso.de/resource/frl:6432076. , 2021

Link: https://repository.publi..

4

Virotherapy in Germany—Recent Activities in Virus Engineeri..:

Nettelbeck, Dirk M ; Leber, Mathias F ; Altomonte, Jennifer...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402873/. , 2021

Link: http://www.ncbi.nlm.nih...

5

Parvovirus-Based Combinatorial Immunotherapy: A Reinforced ..:

Angelova, Assia ; Ferreira, Tiago ; Bretscher, Clemens..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832409/. , 2021

Link: http://www.ncbi.nlm.nih...

6

Virotherapy in Germany—Recent Activities in Virus Engineeri..:

Nettelbeck, Dirk M ; Leber, Mathias F ; Altomonte, Jennifer...
https://mediatum.ub.tum.de/1730547. , 2021

Link: https://mediatum.ub.tum...

7

Immune Conversion of Tumor Microenvironment by Oncolytic Vi..:

Marchini, Antonio ; Daeffler, Laurent ; Pozdeev, Vitaly..
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2019.01848. , 2019

Link: https://hal.science/hal-..

8

Immune Conversion of Tumor Microenvironment by Oncolytic Vi..:

Marchini, Antonio ; Daeffler, Laurent ; Pozdeev, Vitaly I..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692828/. , 2019

Link: http://www.ncbi.nlm.nih...

9

Immune Conversion of Tumor Microenvironment by Oncolytic Vi..:

Marchini, Antonio ; Daeffler, Laurent ; Pozdeev, Vitaly..
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2019.01848. , 2019

Link: https://hal.archives-ouv..

10

Immune System Stimulation by Oncolytic Rodent Protoparvovir..:

Angelova, Assia ; Rommelaere, Jean
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563271/. , 2019

Link: http://www.ncbi.nlm.nih...

11

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hi..:

Angelova, Assia L ; Barf, Milena ; Geletneky, Karsten..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744156/. , 2017

Link: http://www.ncbi.nlm.nih...

12

A non-controlled, single arm, open label, phase II study of..:

Hajda, Jacek ; Lehmann, Monika ; Krebs, Ottheinz...
https://archiv.ub.uni-heidelberg.de/volltextserver/23484/1/12885_2017_Article_3604.pdf. , 2017

Link: https://archiv.ub.uni-he..

13

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunoge..:

Geletneky, Karsten ; Hajda, Jacek ; Angelova, Assia L...
1525-0016. , 2017

Link: https://resolver.sub.uni..

14

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunoge..:

Geletneky, Karsten ; Hajda, Jacek ; Angelova, Assia L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768665/. , 2017

Link: http://www.ncbi.nlm.nih...

15

ATNT-07FAVORABLE RESPONSE OF PATIENTS WITH GLIOBLASTOMA AT ..:

Geletneky, Karsten ; Angelova, Assia ; Leuchs, Barbara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638529/. , 2015

Link: http://www.ncbi.nlm.nih...

1-15